Information:
Fel:
ID
12245
Beskrivning
An open-label, multicenter, randomized, comparative, phase III study to evaluate the efficacy and safety of rituximab plus fludarabine and cyclophosphamide (FCR) versus fludarabine and cyclophosphamide alone (FC) in previously treated patients with CD20 positive B-cell chronic lymphocytic leukemia (CLL). FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients NCT00090051 Roche BO17072
Nyckelord
Versioner (2)
- 2015-09-30 2015-09-30 -
- 2015-10-28 2015-10-28 -
Uppladdad den
28 oktober 2015
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
CLL Hospitalization BO17072 NCT00090051
MRU-Hospitalization of Chronic lymphocytic leukemia NCT0090051
- StudyEvent: ODM
Similar models
MRU-Hospitalization of Chronic lymphocytic leukemia NCT0090051
- StudyEvent: ODM
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Admission date
Item
Admission date
date
C1302393 (UMLS CUI [1])
Discharge date
Item
Discharge date
date
C2361123 (UMLS CUI [1])
Total number of days in ICU
Item
Total number of days in ICU
integer
C0021708 (UMLS CUI [1])
Principal reason for hospitalization
Item
Principal reason for hospitalization
text
C1830395 (UMLS CUI [1])